Assessment of the toxic potential of graphene family nanomaterials

Journal of Food and Drug Analysis

Volumn 22, Issue 1, 2014, Pages 105-115

  Guo, Xiaoqing ^a   Mei, Nan ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Functionalization; Genotoxicity; Graphene; Graphene oxide; Reduced graphene oxide; Toxicity

Indexed keywords

CAMPTOTHECIN; CHITOSAN; DOXORUBICIN; FIRTECAN; FOLIC ACID; GRAPHENE; GRAPHENE OXIDE; MACROGOL; MULTI WALLED NANOTUBE; NANOCOMPOSITE; NANOMATERIAL; SINGLE WALLED NANOTUBE; GRAPHITE;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; BACTERIUM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FOOD INDUSTRY; FOOD PACKAGING; GENOTOXICITY; HUMAN; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; INHALATION; LIQUID CHROMATOGRAPHY; MAMMAL CELL; MEMBRANE DAMAGE; MITOCHONDRIAL TOXICITY; NANOFABRICATION; NANOTOXICOLOGY; NOMENCLATURE; NONHUMAN; OXIDATIVE STRESS; REVIEW; SCREENING; SENSOR; STANDARDIZATION; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; WATER MANAGEMENT; ANIMAL; CHEMISTRY; TOXICITY;

ANIMALIA; MAMMALIA;

ANIMALS; DRUG DELIVERY SYSTEMS; FOOD PACKAGING; GRAPHITE; HUMANS; NANOSTRUCTURES;

EID: 84901609266     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2014.01.009     Document Type: Review

References (99)

1. FDA. Nanotechnology task force report 2007. USFDA; 2007. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/Nanotechnology/ ucm110856.pdf [accessed 04.02.14].
2. Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel. Science 2006;311:622-7.
3. Xia T, Li N, Nel AE. Potential health impact of nanoparticles. Annu Rev Public Health 2009;30:137-50.
4. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823-39.
5. Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science 2004;306:666-9.
6. Geim AK, Novoselov KS. The rise of graphene. Nat Mater 2007;6:183-91.
7. Li D, Müller MB, Gilje S, et al. Processable aqueous dispersions of graphene nanosheets. Nat Nanotechnol 2008;3:101-5.
8. Stankovich S, Dikin DA, Dommett GH, et al. Graphene-based composite materials. Nature 2006;442:282-6.
9. Jaworski S, Sawosz E, Grodzik M, et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int J Nanomedicine 2013;8:413-20.
10. Yang K, Li Y, Tan X, et al. Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small 2012;9:1492-503.
11. Singh N, Srivastava G, Talat M, et al. Cicer alpha-galactosidase immobilization onto functionalized graphene nanosheets using response surface method and its applications. Food Chem 2014;142:430-8.
12. Dikin DA, Stankovich S, Zimney EJ, et al. Preparation and characterization of graphene oxide paper. Nature 2007;448:457-60.
13. Li N, Chen Z, Ren W, et al. Flexible graphene-based lithium ion batteries with ultrafast charge and discharge rates. Proc Natl Acad Sci USA 2012;109:17360-5.
14. Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010;6:537-44.
15. Zhu Z, Garcia-Gancedo L, Flewitt AJ, et al. A critical review of glucose biosensors based on carbon nanomaterials: carbon nanotubes and graphene. Sensors (Basel) 2012;12:5996-6022.
16. Sanchez VC, Jachak A, Hurt RH, et al. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2012;25:15-34.
17. An J, Gou Y, Yang C, et al. Synthesis of a biocompatible gelatin functionalized graphene nanosheets and its application for drug delivery. Mater Sci Eng C Mater Biol Appl 2013;33:2827-37.
18. Liu Y, Yu D, Zeng C, et al. Biocompatible graphene oxide-based glucose biosensors. Langmuir 2010;26:6158-60.
19. Pan Y, Sahoo NG, Li L. The application of graphene oxide in drug delivery. Expert Opin Drug Deliv 2012;9:1365-76.
20. Ahmed F, Rodrigues DF. Investigation of acute effects of graphene oxide on wastewater microbial community: a case study. J Hazard Mater 2013;256-7:33-9.
21. Li Y, Yuan H, von dem Bussche A, et al. Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites. Proc Natl Acad Sci USA 2013;110:12295-300.
22. Yue H, Wei W, Yue Z, et al. The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 2012;33:4013-21.
23. Truong QT, Pokharel P, Song GS, et al. Preparation and characterization of graphene nanoplatelets from natural graphite via intercalation and exfoliation with tetraalkylammoniumbromide. J Nanosci Nanotechnol 2012;12:4305-8.
24. Ali-Boucetta H, Bitounis D, Raveendran-Nair R, et al. Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity. Adv Healthc Mater 2013;2:433-41.
25. Yang K, Zhang S, Zhang G, et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010;10:3318-23.
26. Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 2013;9:9243-57.
27. Yang K, Feng L, Shi X, et al. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev 2013;42:530-47.
28. Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 2008;1:203-12.
29. Liu Z, Robinson JT, Sun X, et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 2008;130:10876-7.
30. Hu H, Yu J, Li Y, et al. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res A 2012;100:141-8.
31. Qin XC, Guo ZY, Liu ZM, et al. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B 2013;120:156-62.
32. Wei G, Yan M, Dong R, et al. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system. Chemistry 2012;18:14708-16.
33. Liu G, Shen H, Mao J, et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. ACS Appl Mater Interfaces 2013;5:6909-14.
34. Wang Y, Wang K, Zhao J, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc 2013;135:4799-804.
35. Wang Z, Zhou C, Xia J, et al. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier. Colloids Surf B Biointerfaces 2013;106:60-5.
36. Miao W, Shim G, Kang CM, et al. Cholesteryl hyaluronic acidcoated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013;34:9638-47.
37. Liu CW, Xiong F, Jia HZ, et al. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model. Biomacromolecules 2013;14:358-66.
38. Arora A, Padua GW. Review: nanocomposites in food packaging. J Food Sci 2010;75:R43-9.
39. Kumar S, Ghosh S, Munichandraiah N, et al. 1.5 V battery driven reduced graphene oxide-silver nanostructure coated carbon foam (rGO-Ag-CF) for the purification of drinking water. Nanotechnology 2013;24:235101.
40. Li YT, Qu LL, Li DW, et al. Rapid and sensitive in-situ detection of polar antibiotics in water using a disposable Aggraphene sensor based on electrophoretic preconcentration and surface-enhanced Raman spectroscopy. Biosens Bioelectron 2013;43:94-100.
41. Jian JM, Liu YY, Zhang YL, et al. Fast and sensitive detection of Pb2+ in foods using disposable screen-printed electrode modified by reduced graphene oxide. Sensors (Basel) 2013;13:13063-75.
42. Santos CM, Mangadlao J, Ahmed F, et al. Graphene nanocomposite for biomedical applications: fabrication, antimicrobial and cytotoxic investigations. Nanotechnology 2012;23:395101.
43. Hu W, Peng C, Luo W, et al. Graphene-based antibacterial paper. ACS Nano 2010;4:4317-23.
44. Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 2010;4:5731-6.
45. Liu S, Zeng TH, Hofmann M, et al. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 2011;5:6971-80.
46. Gurunathan S, Han JW, Dayem AA, et al. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine 2012;7:5901-14.
47. Tu Y, Lv M, Xiu P, et al. Destructive extraction of phospholipids from Escherichia coli membranes by graphene nanosheets. Nat Nanotechnol 2013;8:594-601.
48. Sawangphruk MS, Srimuka P, Chiochan P, et al. Synthesis and antifungal activity of reduced graphene oxide nanosheets. Carbon 2012;50:5156-61.
49. Li C, Wang X, Chen F, et al. The antifungal activity of graphene oxide-silver nanocomposites. Biomaterials 2013;34:3882-90.
50. Tang J, Chen Q, Xu L, et al. Graphene oxide-silver nanocomposite as a highly effective antibacterial agent with species-specific mechanisms. ACS Appl Mater Interfaces 2013;5:3867-74.
51. Liu L, Bai H, Liu J, et al. Multifunctional graphene oxide-TiOAg nanocomposites for high performance water disinfection and decontamination under solar irradiation. J Hazard Mater 2013;261:214-23.
52. Ouyang Y, Cai X, Shi Q, et al. Poly-L-lysine-modified reduced graphene oxide stabilizes the copper nanoparticles with higher water-solubility and long-term additively antibacterial activity. Colloids Surf B Biointerfaces 2013;107:107-14.
53. Ruiz ON, Fernando KA, Wang B, et al. Graphene oxide: a nonspecific enhancer of cellular growth. ACS Nano 2011;5:8100-7.
54. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 2010;28:580-8.
55. Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 2010;4:3181-6.
56. Yuan J, Gao H, Ching CB. Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LCMS/ MS proteome analysis. Toxicol Lett 2011;207:213-21.
57. Li Y, Liu Y, Fu Y, et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials 2012;33:402-11.
58. Sasidharan A, Panchakarla LS, Sadanandan AR, et al. Hemocompatibility and macrophage response of pristine and functionalized graphene. Small 2012;8:1251-63.
59. Schinwald A, Murphy FA, Jones A, et al. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 2012;6:736-46.
60. Chang Y, Yang ST, Liu JH, et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 2011;200:201-10.
61. Hu W, Peng C, Lv M, et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011;5:3693-700.
62. Lammel T, Boisseaux P, Fernández-Cruz ML, et al. Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2. Part Fibre Toxicol 2013;10:27.
63. Yuan J, Gao H, Sui J, et al. Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol Sci 2012;126:149-61.
64. Zhang H, Peng C, Yang J, et al. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake. ACS Appl Mater Interfaces 2013;5:1761-7.
65. Zhang X, Hu W, Li J, et al. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol Res 2012;1:62-8.
66. Lv M, Zhang Y, Liang L, et al. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale 2012;4:3861-6.
67. Wang A, Pu K, Dong B, et al. Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene-oxide towards human lung fibroblast cells. J Appl Toxicol 2013;33:1156-64.
68. Wang K, Ruan J, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett 2011;6:8-15.
69. Vallabani NV, Mittal S, Shukla RK, et al. Toxicity of graphene in normal human lung cells (BEAS-2B). J Biomed Nanotechnol 2011;7:106-7.
70. Kang SM, Kim TH, Choi JW. Cell chip to detect effects of graphene oxide nanopellet on human neural stem cell. J Nanosci Nanotechnol 2012;12:5185-90.
71. Yan L, Wang Y, Xu X, et al. Can graphene oxide cause damage to eyesight? Chem Res Toxicol 2012;25:1265-70.
72. Qu G, Liu S, Zhang S, et al. Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages. ACS Nano 2013;7:5732-45.
73. Zhi X, Fang H, Bao C, et al. The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials 2013;34:5254-61.
74. Chen GY, Yang HJ, Lu CH, et al. Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials 2012;33:6559-69.
75. Liao KH, Lin YS, Macosko CW, et al. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces 2011;3:2607-15.
76. Singh SK, Singh MK, Nayak MK, et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 2011;5:4987-96.
77. Agarwal S, Zhou X, Ye F, et al. Interfacing live cells with nanocarbon substrates. Langmuir 2010;26:2244-7.
78. Akhavan O, Ghaderi E, Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 2012;33:8017-25.
79. Gurunathan S, Han JW, Eppakayala V, et al. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int J Nanomedicine 2013;8:1015-27.
80. Zhi F, Dong H, Jia X, et al. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS One 2013;8:e60034.
81. Sahoo NG, Bao H, Pan Y, et al. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem Commun (Camb) 2011;47:5235-7.
82. Bao H, Pan Y, Ping Y, et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 2011;7:1569-78.
83. Wan M, Liu Z, Li S, et al. Silver nanoaggregates on chitosan functionalized graphene oxide for high-performance surface-enhanced Raman scattering. Appl Spectrosc 2013;67:761-6.
84. Sasidharan A, Panchakarla LS, Chandran P, et al. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 2011;3:2461-4.
85. Singh SK, Singh MK, Kulkarni PP, et al. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano 2012;6:2731-40.
86. Tan X, Feng L, Zhang J, et al. Functionalization of graphene oxide generates a unique interface for selective serum protein interactions. ACS Appl Mater Interfaces 2013;5:1370-7.
87. Robinson JT, Tabakman SM, Liang Y, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc 2011;133:6825-31.
88. Mullick Chowdhury S, Lalwani G, Zhang K, et al. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 2013;34:283-93.
89. Liu JH, Yang ST, Wang H, et al. Effect of size and dose on the biodistribution of graphene oxide in mice. Nanomedicine (Lond) 2012;7:1801-12.
90. Duch MC, Budinger GR, Liang YT, et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett 2011;11:5201-7.
91. Bianco A. Graphene: safe or toxic? The two faces of the medal. Angew Chem Int Ed Engl 2013;52:4986-97.
92. Wang X, Podila R, Shannahan JH, et al. Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int J Nanomed 2013;8:1733-48.
93. Yang K, Gong H, Shi X, et al. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 2013;34:2787-95.
94. Yang K, Wan J, Zhang S, et al. In vivo pharmacokinetics, longterm biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2011;5:516-22.
95. Ma-Hock L, Strauss V, Treumann S, et al. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 2013;10:23.
96. Wu Q, Yin L, Li X, et al. Contributions of altered permeability of intestinal barrier and defecation behavior to toxicity formation from graphene oxide in nematode Caenorhabditis elegans. Nanoscale 2013;5:9934-43.
97. Zanni E, De Bellis G, Bracciale MP, et al. Graphite nanoplatelets and Caenorhabditis elegans: insights from an in vivo model. Nano Lett 2012;12:2740-4.
98. Zhang W, Wang C, Li Z, et al. Unraveling stress-induced toxicity properties of graphene oxide and the underlying mechanism. Adv Mater 2012;24:5391-7.
99. Chng EL, Pumera M. The toxicity of graphene oxides: dependence on the oxidative methods used. Chemistry 2013;19:8227-35.